Cresco Labs Statistics

Total Valuation

Cresco Labs has a market cap or net worth of CAD 744.21 million. The enterprise value is 1.40 billion.

Market Cap	744.21M
Enterprise Value	1.40B

Important Dates

The next estimated earnings date is Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Cresco Labs has 347.76 million shares outstanding. The number of shares has increased by 11.58% in one year.

Shares Outstanding	347.76M
Shares Change (YoY)	+11.58%
Shares Change (QoQ)	+0.97%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	7.77%
Float	326.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.73
PB Ratio	1.16
P/FCF Ratio	8.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.95, with an EV/FCF ratio of 16.08.

EV / Earnings	-5.92
EV / Sales	1.39
EV / EBITDA	4.95
EV / EBIT	9.25
EV / FCF	16.08

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 1.82.

Current Ratio	2.00
Quick Ratio	1.22
Debt / Equity	1.82
Debt / EBITDA	3.31
Debt / FCF	10.75
Interest Coverage	1.95

Financial Efficiency

Return on equity (ROE) is -35.12% and return on invested capital (ROIC) is 6.08%.

Return on Equity (ROE)	-35.12%
Return on Assets (ROA)	4.81%
Return on Capital (ROIC)	6.08%
Revenue Per Employee	346,798
Profits Per Employee	-81,393
Employee Count	2,760
Asset Turnover	0.51
Inventory Turnover	3.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.42% in the last 52 weeks. The beta is 1.97, so Cresco Labs's price volatility has been higher than the market average.

Beta (5Y)	1.97
52-Week Price Change	+17.42%
50-Day Moving Average	2.22
200-Day Moving Average	2.48
Relative Strength Index (RSI)	38.72
Average Volume (20 Days)	141,732

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cresco Labs had revenue of CAD 1.01 billion and -236.04 million in losses. Loss per share was -0.69.

Revenue	1.01B
Gross Profit	498.39M
Operating Income	151.00M
Pretax Income	-179.79M
Net Income	-236.04M
EBITDA	241.07M
EBIT	151.00M
Loss Per Share	-0.69

Full Income Statement

Balance Sheet

The company has 153.69 million in cash and 933.62 million in debt, giving a net cash position of -779.92 million or -2.24 per share.

Cash & Cash Equivalents	153.69M
Total Debt	933.62M
Net Cash	-779.92M
Net Cash Per Share	-2.24
Equity (Book Value)	512.57M
Book Value Per Share	1.84
Working Capital	186.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 124.48 million and capital expenditures -37.62 million, giving a free cash flow of 86.86 million.

Operating Cash Flow	124.48M
Capital Expenditures	-37.62M
Free Cash Flow	86.86M
FCF Per Share	0.25

Full Cash Flow Statement

Margins

Gross margin is 49.56%, with operating and profit margins of 15.01% and -23.47%.

Gross Margin	49.56%
Operating Margin	15.01%
Pretax Margin	-17.88%
Profit Margin	-23.47%
EBITDA Margin	23.97%
EBIT Margin	15.01%
FCF Margin	8.64%

Dividends & Yields

Cresco Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.58%
Shareholder Yield	-11.58%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cresco Labs has an Altman Z-Score of -0.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.07
Piotroski F-Score	n/a